Dynamic Contrast-Enhanced MRI Kinetic Parameters as Prognostic Biomarkers for Prediction of Survival of Patient with Advanced Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Dynamic Contrast-Enhanced MRI Kinetic Parameters as Prognostic Biomarkers for Prediction of Survival of Patient with Advanced Hepatocellular Carcinoma

Published:2015-11 Issue:11 Volume:22 Page:1344-1360
ISSN:1076-6332
Container-title:Academic Radiology
language:en
Short-container-title:Academic Radiology

Author:

Lee Sang Ho^ORCID,Hayano Koichi,Zhu Andrew X.,Sahani Dushyant V.,Yoshida Hiroyuki

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging

Reference50 articles.

1. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions;Padhani;J Magn Reson Imaging,2002

2. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival;Jarnagin;Ann Oncol,2009

3. Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response;Yopp;Ann Surg Oncol,2011

4. Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy;Sahani;J Hematol Oncol,2013

5. Estimation of hepatic arterial and portal venous blood flow by direct catheterization of the vena porta through the umbilical cord in man. Preliminary results;Chiandussi;Acta Hepatosplenol,1968

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing pseudo‐spiral sampling for abdominal DCE MRI using a digital anthropomorphic phantom;Magnetic Resonance in Medicine;2024-07-14

2. Establishment and Validation of a Novel MRI Radiomics Feature-Based Prognostic Model to Predict Distant Metastasis in Endemic Nasopharyngeal Carcinoma;Frontiers in Oncology;2022-03-23

3. Applying arterial enhancement fraction (AEF) texture features to predict the tumor response in hepatocellular carcinoma (HCC) treated with Transarterial chemoembolization (TACE);Cancer Imaging;2021-08-12

4. BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy;BioMed Research International;2021-04-19

5. Dynamic contrast‑enhanced MRI differentiates hepatocellular carcinoma from hepatic metastasis of rectal cancer by extracting pharmacokinetic parameters and radiomic features;Experimental and Therapeutic Medicine;2020-08-07